An in-depth look to SAMSUNG PHARMACEUTICAL operating, investing, and financing activities

001360 free cash flow for Q3 24 is -2.58 B KRW. For 2023, 001360 free cash flow was -28.43 B KRW and operating cash flow was -27.66 B KRW.